title: Lisdexamfetamine dimesylate.
authors.forename: Josephine
authors.initials: J
authors.lastname: Elia
authors.forename: Chris
authors.initials: C
authors.lastname: Easley
authors.forename: Peter
authors.initials: P
authors.lastname: Kirkpatrick
mesh_terms: D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy* / Q000503:physiopathology / Q000523:psychology; D000697:Central Nervous System Stimulants / Q000627:therapeutic use*; D002648:Child; D003913:Dextroamphetamine / Q000627:therapeutic use*; D004298:Dopamine / Q000502:physiology; D017277:Drug Approval; D006801:Humans; D000069478:Lisdexamfetamine Dimesylate; D009638:Norepinephrine / Q000502:physiology; D011355:Prodrugs / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D019966:Substance-Related Disorders / Q000523:psychology; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D000697:Central Nervous System Stimulants; D011355:Prodrugs; D000069478:Lisdexamfetamine Dimesylate; D003913:Dextroamphetamine; D004298:Dopamine; D009638:Norepinephrine